Clinical Trials Logo

Clinical Trial Summary

This randomized, placebo-controlled trial will evaluate the use of donepezil compared to placebo to reduce the risk of memory impairment after electroconvulsive therapy (ECT).


Clinical Trial Description

Electroconvulsive therapy (ECT) is a method used to treat a variety of psychiatric conditions. An electrical current is distributed throughout the brain (Lisanby 2007) inducing seizure activity in a controlled setting using neuromuscular blocking agents (Mirzakhani 2012) while the patient is under anesthesia (Deiner 2009). ECT is approved by the Food and Drug Administration (FDA) for the following conditions: unipolar and bipolar depression, manic and mixed states in bipolar disorder, schizophrenia, schizoaffective disorder, schizophreniform disorder and catatonia (FDA executive summary). ECT is often used after trials of psychotropic medications have failed (Kellner 2012).

Electroconvulsive therapy (ECT) is commonly associated with cognitive side effects that range from anterograde and retrograde amnesia to issues with executive function, attention and declines in information processing. Problems with autobiographical memory and recall for new information appear to be affected the most. In addition, data suggests that the loss of memory of autobiographical events may persist as long as six months. These issues may cause patient adherence problems and potential relapses into previous psychiatric conditions.

Donepezil is an acetylcholinesterase inhibitor indicated for Alzheimer's Dementia and has been shown to slow the progressive decline in cognition and memory in Alzheimer's Dementia. It is hypothesized that donepezil will help to preserve memory and minimize the decline in memory that is associated with the administration of ECT.

This study aims to determine if donepezil can minimize deficiencies in autobiographical memory 4-5 weeks after ECT treatment has been started. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02331771
Study type Interventional
Source Porter Adventist Hospital
Contact
Status Terminated
Phase N/A
Start date September 24, 2015
Completion date March 24, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03896529 - Neurobiological Mechanisms of Aging and Stress on Prospective Navigation N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT00736034 - The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment Phase 4
Completed NCT04910399 - Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging N/A
Completed NCT02814526 - Exercise in Adults With Mild Memory Problems N/A
Recruiting NCT05289804 - Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment Phase 1/Phase 2
Completed NCT04955457 - BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.
Completed NCT05033262 - Our Care Wishes - Dementia N/A
Recruiting NCT01919957 - Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies N/A
Not yet recruiting NCT01708200 - A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness. N/A
Recruiting NCT04583215 - Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Active, not recruiting NCT03205709 - Cognitive Training and Neuroplasticity in Mild Cognitive Impairment N/A
Recruiting NCT02302482 - Predictive Factors and Autonomy Level Change N/A
Completed NCT02301247 - Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS) N/A
Completed NCT01708304 - Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) N/A
Recruiting NCT06025877 - Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
Recruiting NCT05122598 - Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease Phase 2
Completed NCT04473235 - Better Memory With Literacy Acquisition Later in Life N/A
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A